Vaccine leader’s net profit jumped 209% last year, but employees were given “big bonuses” before the holiday

2022-07-19 0 By

On the evening of February 8, the intelligent flying biology released the 2021 annual performance express shows that the company achieved operating revenue of about 30.637 billion yuan, a year-on-year increase of 101.68%;The net profit attributable to shareholders of listed companies was about 10.197 billion yuan, an increase of 208.88% year-on-year.For the performance changes, Zhifei bio said that during the reporting period, the company closely around the business development goals continue to make efforts, increase investment in research and development to bring forth the new, independent products and agent products sales have continued to steadily improve, the company’s main business income, net profit and other important financial indicators have increased significantly compared with the same period last year.Earlier, intelligence flying biology for employees to pay “big red envelope” news has attracted attention from the capital market.Looking back, on the evening of January 28, the company announced that it had reviewed and approved the Draft of The Employee Stock Ownership Plan for Common Prosperity (2022) at the board meeting held on the same day. The total amount of funds raised in this plan is not more than 1.6 billion yuan, and the total share of the plan is not more than 1.6 billion yuan, and the amount of each share is 1 yuan.It is understood that the company will launch the employee stock ownership plan to improve the cohesion of employees, attract and retain excellent management talents and business backbone, the total number of beneficiaries is expected to reach 2000 people, which is rare in the A-share market.Weekly (article | the financial world Tang Guo)